Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VPI-2690B in Diabetic Nephropathy
NCT02251067Phase 2Completed
- Sponsor
- Vascular Pharmaceuticals, Inc.
- Start
- Sep 2014
- Primary completion
- Mar 2017
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of VPI-2690B in diabetic nephropathy (DN), sponsored by Vascular Pharmaceuticals, Inc.. Started Sep 2014; status: completed.
02
Drugs
VPI-2690B
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT02251067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02251067.